American Gene Technologies
Developing Therapeutics That Teach the Body to Heal Itself
Latest HIV Cure Project Update
Gene and cell therapies like AGT103-T are tested on patients who have the target disease, giving us a sneak peek at efficacy data that normally occurs in Phase 2. The first efficacy signal will be objective markers in participant blood tests... stay tuned in December!
First Five Patients Show Critical Efficacy Markers.
American Gene Technologies’ HIV Clinical Trial Demonstrates Blood Markers of Efficacy
American Gene Technologies Inc.
We send out quarterly newsletters that keep you up-to-date on all our projects, progress, and events.